Keyphrases
Prognostic Value
88%
Diastolic Function
81%
Major Adverse Cardiovascular Events
79%
Diastolic Dysfunction
68%
Aortic Valve Surgery
68%
Type 2 Diabetes Mellitus (T2DM)
54%
Myocardial Performance Index
54%
Type I Diabetes
54%
Type 1 Diabetes Mellitus (T1DM)
54%
Filling Speed
54%
Transmitral
54%
Diastolic Parameters
54%
Repeatability
54%
Failure Impact
54%
Diastolic Strain Rate
54%
Chronic Heart Failure
54%
Severe Aortic Regurgitation
54%
Adrenoceptor Agonist
54%
End-diastolic Volume
54%
Agonist Treatment
54%
First-in-man Trial
54%
Layer-specific Strain
54%
Heart Failure
47%
Global Longitudinal Strain
44%
Echocardiography
43%
Vmax
40%
Placebo
40%
Endocardium
32%
Between-group
27%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
27%
Cardiac Computed Tomography
27%
Mirabegron
27%
Reduced Ejection Fraction
27%
All-cause Mortality
24%
Follow-up Data
20%
E-HR
18%
Multivariable
18%
Area under the Curve
16%
Risk Engine
15%
Steno
15%
Echocardiogram
13%
Echocardiographic Indices
13%
Diabetes
13%
Reclassification
13%
Indexing Algorithm
13%
Inter-examiner
13%
Interobserver Variability
13%
Left Atrial Volume
13%
Classification Algorithms
13%
Interobserver
13%
Medicine and Dentistry
Diastolic Function
100%
Heart Failure
88%
Aortic Valve Surgery
72%
Diastolic Dysfunction
72%
Echocardiography
61%
Reproducibility
54%
Aortic Insufficiency
54%
Maturity Onset Diabetes of the Young
54%
End-Diastolic Volume
54%
Heart Performance
54%
Insulin Dependent Diabetes Mellitus
54%
Sympathomimetic Drug
54%
Cardiovascular System
45%
Cardiovascular Disease
40%
Placebo
40%
Endocardium
32%
Amino Terminal Sequence
27%
Isotopes of Calcium
27%
Mirabegron
27%
Cardiac Computed Tomography
27%
Ejection Fraction
27%
Natriuretic Factor
27%
All Cause Mortality
24%
Diabetes
22%
Coronary Artery Bypass Graft
18%
Mitral Valve
18%
E/A Ratio
18%
Tricuspid Insufficiency
18%
Beta 3 Adrenergic Receptor Stimulating Agent
13%
Ischemic Heart Disease
13%
Biological Marker
13%
Calcium Transport
13%
Adrenergic Receptor
13%
Sodium Ion
13%
Sodium Calcium Exchange Protein
13%
Heart Left Ventricle Ejection Fraction
13%
Patient with Type 1 Diabetes
9%
Diabetic Cardiomyopathy
9%
Heart Disease
9%
Acute Coronary Syndrome
6%
Apoplexy
6%
Myocardium
6%
Prospective Cohort Study
6%
Heart Left Ventricle Function
6%
Heart Function
6%